trending Market Intelligence /marketintelligence/en/news-insights/trending/qbsmld-grnpm32kjndflzq2 content esgSubNav
In This List

Takeda to invest €25M, add 70 jobs in new Dublin facility

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Takeda to invest €25M, add 70 jobs in new Dublin facility

Takeda Pharmaceutical Co. Ltd. will invest €25 million and create up to 70 jobs in the construction of a new regenerative medicine facility in Dublin.

The Japanese pharmaceuticals company is set to build a new modular cell therapy facility to manufacture new stem cell therapy. The investment will also expand the company's existing facility in Grange Castle.

The new jobs will be in the quality, manufacturing and engineering sectors, Takeda Ireland Grange Castle's Plant Director Paul Keogh said.

Takeda's project is supported by the Irish government through IDA Ireland, the government agency responsible for attracting and developing foreign direct investment in the country.